GABRIELA ORTIZ: Open Payments
NPI 1326803347 · HUNTINGTON PARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,441 in 44 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,160 · 2025 $1,441
Food & beverage: $1,441
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 8 | $388 |
| Galderma Laboratories, L.P. | 9 | $280 |
| Incyte Corporation | 9 | $227 |
| Organon LLC | 5 | $197 |
| Novartis Pharmaceuticals Corporation | 4 | $101 |
| ABBVIE INC. | 2 | $64 |
| UCB, Inc. | 2 | $63 |
| GENZYME CORPORATION | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $29 |
Products named: Zoryve, NEMLUVIO, OPZELURA, VTAMA, DUPIXENT, COSENTYX, SKYRIZI, Bimzelx.
Industry payments across CA — which companies pay providers there.
